Rockwell Medical Q4 gross margin rises to 22% with net sales of USD 18.6 million
I'm PortAI, I can summarize articles.
Rockwell Medical Inc. reported preliminary unaudited financial results for Q4 and FY 2025, with expected net sales of approximately USD 18.6 million for Q4 and USD 69.5 million for the full year. The gross margin for Q4 is anticipated to be around 22%. Additionally, cash flow from operations for Q4 is expected to be about USD 2.3 million, with cash and cash equivalents totaling approximately USD 25 million as of December 31, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments